115 related articles for article (PubMed ID: 3528419)
1. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.
Mainguené C; Aillet G; Kremer M; Chatal JF
J Nucl Med Allied Sci; 1986; 30(1):19-22. PubMed ID: 3528419
[No Abstract] [Full Text] [Related]
2. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
3. Potential usefulness of monoclonal antibodies in invasive ovarian adenocarcinoma.
Patsner B; Day TG; Rao CV
J Ky Med Assoc; 1986 Nov; 84(11):613-5. PubMed ID: 3466996
[No Abstract] [Full Text] [Related]
4. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
Lian LJ; Hu XF; Liu WS; Wu AJ
Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
[No Abstract] [Full Text] [Related]
6. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
Flynn MK; Johnston W; Bigner S
Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
8. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
9. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
Bar J; Sobańska E
Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
[TBL] [Abstract][Full Text] [Related]
12. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers as a diagnostic tool in ovarian neoplasms].
Czernobilsky B
Verh Dtsch Ges Pathol; 1986; 70():184-9. PubMed ID: 2435074
[No Abstract] [Full Text] [Related]
14. Antigens associated with epithelial ovarian carcinomas.
Bast RC
Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
[No Abstract] [Full Text] [Related]
15. CA-125: An evaluation.
Nuss R; Swor MG; Benrubi MD
J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
[No Abstract] [Full Text] [Related]
16. Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.
Masuho Y; Zalutsky M; Knapp RC; Bast RC
Cancer Res; 1984 Jul; 44(7):2813-9. PubMed ID: 6202400
[TBL] [Abstract][Full Text] [Related]
17. [CA 125--a new characteristic in the diagnosis of ovarian carcinoma].
Tosner J
Cesk Gynekol; 1987 Jun; 52(5):381-5. PubMed ID: 3477330
[No Abstract] [Full Text] [Related]
18. Immunohistochemical detection of the Ca antigen in normal and tumor tissues of humans by use of Ca1 monoclonal antibody.
Woodhouse CS; Seiler C; Morgan AC; Oldham RK
J Natl Cancer Inst; 1985 Feb; 74(2):383-9. PubMed ID: 3883035
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of the CA-125 assay for the management of patients with ovarian carcinoma.
Raju RN; Dalbow MH; Pugh RP; Concannon JP; Zidar BL; Zamerilla CF; Schenken LL
Prog Clin Biol Res; 1987; 248():289-97. PubMed ID: 3478733
[No Abstract] [Full Text] [Related]
20. Identification of a meiotically expressed carbohydrate antigen in ovarian carcinoma: I. Immunohistochemical localization.
Skinner SM; Lee VH; Kieback DG; Jones LA; Kaplan AL; Dunbar BS
Anticancer Res; 1997; 17(2A):901-6. PubMed ID: 9137425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
